(EMAILWIRE.COM, March 07, 2019 ) According to the new market research report "Amniocentesis Needle Market by Type (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), Procedure (Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion), End User (Hospitals, Diagnostic Centers, Clinics) - Global Forecast to 2022", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Don’t miss out on business opportunities in Amniocentesis Needle Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=18541768

The amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%.
The base year for this study is 2016 and the forecast period is 2017–2022. 100–150 mm needles are the most commonly used amniocentesis needles and are expected to account for the largest share of the global market in 2017. The large share of this segment can be attributed to the fact that these needles are suitable for most patients on account of their optimal length.

This type of needle is suitable for use in females with a normal body-mass index (BMI) of 18.50–24.99 kg/m2. There is an increase in the proportion of women who are overweight, this proportion will still be lesser than the proportion of women with normal BMI. This is one of the major factors responsible for the large share of 100–150 mm needles in the amniocentesis needles market. Amniocentesis procedure is the most commonly recommended invasive prenatal diagnostic test to detect chromosomal disorders, infections, or birth defects. In spite of a small proportion of risks associated with this procedure, amniocentesis is carried out to diagnose the abnormalities in the developing fetus. These are the major factors responsible for the large share of this procedure segment in the amniocentesis needles market.

Browse and in-depth TOC on "Amniocentesis Needle Market"
74 – Tables
34 - Figures
132 - Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html

By procedure, the market is classified into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is estimated to account for the largest share of the global amniocentesis needles market during the next five years. High reliability of the amniocentesis technique and the extensive use of this procedure to diagnose the abnormalities in the developing fetus are driving the growth of this market.

On the basis of end user, the amniocentesis needles market is segmented into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768

Key Players:
The key players in the amniocentesis needles market include Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), Cook Medical (US), Laboratoire CCD (France), Biopsybell (Italy), RI.MOS. (Italy), TSUNAMI MEDICAL (Italy), and Rocket Medical (UK).